Resumen de Pancreatic ductal adenocarcinoma: metastatic disease

Andrés Jesús Muñoz Martín, J. Adeva, J. Martinez Galán, J. J. Reina Zoiló, Manuel Hidalgo Medina

• The treatment of choice of metastatic PADC is systemic chemotherapy. In the last decade, there have been significant advances in this area. New combination poli-chemotherapy schemes have shown a significant increase in overall survival and progression-free survival without impairing quality of life. In addition, the value of second-line chemotherapy treatment has consolidated and a new concept called “therapeutic sequencing” has also emerged. The aim of this article is to review the different therapeutic options in metastatic PDAC based on patient’s characteristics.